Sandeep Laumas's Net Worth

-$38.9 Thousand

Estimate Recalculated Dec 4, 2024 09:06PM EST

Who is Sandeep Laumas

Sandeep Laumas does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Instil Bio, Inc., BioXcel Therapeutics, Inc., Unicycive Therapeutics, Inc., Hillstream BioPharma Inc., and INNOVATE BIOPHARMACEUTICALS, INC..

SEC CIK

Sandeep Laumas's CIK is 0001721664

Past Insider Trading and Trends

2018 was Sandeep Laumas's most active year for acquiring shares with 13 total transactions. Sandeep Laumas's most active month to acquire stocks was the month of April. 2020 was Sandeep Laumas's most active year for disposing of shares, totalling 1 transactions. Sandeep Laumas's most active month to dispose stocks was the month of May. 2022 saw Sandeep Laumas paying a total of $2,017,080.00 for 485,000 shares, this is the most they've acquired in one year. In 2020 Sandeep Laumas cashed out on 424 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Instil Bio, Inc.

CFO and CBO
Updated Feb 13, 2024
Form 4
80.00K
Feb 13, 2024
80.00K
Grant
Feb 10
Form 4/A
234.00K
Jan 20, 2023
234.00K
Grant
Mar 04
Form 4
415.00K
Jan 20, 2023
415.00K
Grant
Jan 08
Form 4
234.00K
$8.62
$2.02M
Mar 07, 2022
234.00K
Grant
Mar 04
Form 4
200.00K
May 13, 2021
200.00K
Grant
May 11
Form 4
240.00K
Mar 22, 2021
240.00K
Grant
Mar 18
Form 3
Mar 18, 2021
3.20M
Showing 7 results

BioXcel Therapeutics, Inc.

Investor
Updated Jun 11, 2024
Form 4
17.00K
Jun 11, 2024
17.00K
Grant
Jun 10
Form 4
17.00K
Jun 28, 2023
17.00K
Grant
Jun 26
Form 4
17.00K
May 23, 2022
17.00K
Grant
May 19
Form 4
14.50K
Jun 15, 2021
14.50K
Grant
Jun 11
Form 4
20.00K
May 26, 2020
20.00K
Grant
May 21
Form 4
14.70K
May 28, 2019
14.70K
Grant
May 23
Form 4
42.78%
37.21K
Mar 13, 2018
124.19K
Grant
Mar 12
Form 3
Mar 07, 2018
Showing 8 results

Unicycive Therapeutics, Inc.

Investor
Updated Sep 07, 2023
Form 4
1,627.42%
189.24K
Sep 07, 2023
200.86K
Grant
Sep 05
Form 3
Jul 12, 2021
105.82K
Showing 2 results

Hillstream BioPharma Inc.

Investor
Updated Jan 11, 2022
Form 3
Jan 11, 2022
636.01K
Showing 1 results

9 METERS BIOPHARMA, INC.

CEO, Executive Chairman
Updated Jul 08, 2020
Form 4
150.00K
Jul 08, 2020
150.00K
Grant
Jul 06
Form 4
227.83%
41.98K
Jul 02, 2020
818.77K
Options
Jun 30
Form 4
1.01%
848.00
May 04, 2020
84.80K
Purchase
May 04
Form 4
389.29K
May 04, 2020
389.29K
Grant
Apr 24
Form 4
400.00K
Aug 27, 2019
400.00K
Grant
Aug 20
Form 4
28.57%
4.00K
$1.15
$4.60K
Jul 01, 2019
776.37K
Purchase
Jun 28
Form 4
7.69%
1.00K
$1.22
$1.22K
Jun 17, 2019
772.37K
Purchase
Jun 13
Form 4
62.50%
5.00K
$1.38
$6.90K
May 23, 2019
771.37K
Purchase
May 22
Form 4
60.00%
3.00K
$2.63
$7.89K
Dec 03, 2018
766.37K
Purchase
Nov 30
Form 4
150.00%
3.00K
$2.56
$7.67K
Nov 29, 2018
763.37K
Purchase
Nov 29
Form 4
33.33%
500.00
$6.10
$3.05K
Sep 10, 2018
760.37K
Purchase
Sep 07
Form 4
200.00%
500.00
$5.24
$2.62K
Aug 30, 2018
759.12K
Purchase
Aug 30
Form 4/A
250.00
$4.90
$1.23K
Aug 30, 2018
758.62K
Purchase
Aug 28
Form 4
300.00%
750.00
$5.01
$3.76K
Aug 28, 2018
1.00K
Purchase
Aug 28
Form 3
Feb 08, 2018
758.37K
Showing 15 results